ADAPTIMMUNE THERAPEUTICS PLC
Cash Flow Statement
| Line Item | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-30.3M | $-47.6M | $-17.6M | $69.5M | $-48.5M | $-45.6M | $-21.4M | $1.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $2.3M | — | — | $2.8M | — | — | $1.7M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $669.0K | — | — | $3.1M | — | — | $1.7M |
| Net Cash from Operating Activities | $-34.8M | $-66.6M | $-54.5M | $47.4M | $-32.0M | $-45.2M | $-43.8M | $-37.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $75.0K | $1.2M | $143.0K | $422.0K | $102.0K | $289.0K | $1.2M | $2.3M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $41.2M | — | — | $-358.0K | — | — | $48.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-25.3M | — | — | $29.2M | — | — | $196.0K |
| Net Change in Cash | — | $-50.2M | — | — | $-3.5M | — | — | $11.8M |
| Free Cash Flow | $-34.9M | $-67.8M | $-54.6M | $47.0M | $-32.1M | $-45.4M | $-45.0M | $-39.6M |